Madrigal Pharmaceuticals Tech Stack
Clinical-stage biotech developing MASH therapeutics with AI-driven operations
Madrigal is a public biopharmaceutical company developing treatments for metabolic dysfunction-associated steatohepatitis (MASH), a progressive liver disease. The tech stack reveals a company mid-build on AI and data infrastructure—adopting AutoGen, CrewAI, and Langfuse alongside traditional pharma tools (Veeva RIM, dbt, Databricks)—while hiring heavily in healthcare, research, and sales roles at director and senior levels. Active projects span clinical trial execution, regulatory submissions, and real-world evidence generation, aligned with multiple pain points around document efficiency, compliance (SOX 404, TMF archival), and trial scaling.
Tech Stack 27 technologies
What Madrigal Pharmaceuticals Is Building
◆Challenges
- Ensuring right talent
- Ensuring compliance with sox 404
- Optimal pricing and reimbursement
- Optimizing document development efficiency
- Improving patient access and adherence
- Mitigate supply chain disruptions
- Ensuring tmf health and archival
- Compliance issues
- Expanding clinical trial operations
- Strengthening workforce strategy
▲Active Projects
- Analytics
- Clinical trial documentation for phase 1-4
- Global clinical trial execution
- Regulatory strategy for nda/bla submissions
- Global integrated evidence plans
- Business development and m&a projects
- Real-world evidence generation
- Marketing initiatives targeting endocrinologists
- Standard reporting for ongoing compliance check
- Medical information resource document development
Hiring Activity
Department
Seniority
Notable leadership hires: Health Systems Director, Scientific Director, Medical Director, HR Communications Director, Key Account Director
